1-4 of 4
Wynne Weston-Davies
Close
Sort by
Journal Articles

Long Term Nomacopan Administration Results in Complete Transfusion Independence in Previously Transfusion-Dependent PNH Patients

Austin Kulasekararaj, MBBS MDMRCP FRCPath, Wynne Weston-Davies, Tadeusz Robak, MD, Miles Nunn, PhD, Agnieszka Piekarska, MD, Anna Szmigielska-Kaplon, MD, Anita Hill, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4797.
https://doi.org/10.1182/blood-2019-125263
Published: 2019
Journal Articles

Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial

Anita Hill, MBChB (Hons), PhD, Wynne Weston-Davies, MB FRCS, Miles Nunn, PhD, Tadeusz Robak, MD PhD, Jerzy Windyga, MD, Andrzej Hellmann, MD PhD DSc, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Agniezka Piekarska, Anna Szmigielska-Kaplon, Morag Griffin, Talha Munir
Journal: Blood
Blood (2017) 130 (Supplement 1): 4747.
https://doi.org/10.1182/blood.V130.Suppl_1.4747.4747
Published: 2017
Journal Articles

Coversin Blocked in Vitro Hemolysis in an Eculizumab-Resistant PNH Patient with the C5 Polymorphism (c.2654G>A)

Yasutaka Ueda, MDPhD, Makiko Osato, DS, Wynne Weston-Davies, MB FRCS, Miles A Nunn, DPhil, Satoru Hayashi, Jun-Ichi Nishimura, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2138.
https://doi.org/10.1182/blood.V126.23.2138.2138
Published: 2015
Journal Articles

C5 Polymorphism in a Dutch Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) and No Asian Ancestry, Resistant to Eculizumab, but in Vitro Sensitive to Coversin

Saskia Langemeijer, MD PhD, Jun-Ichi Nishimura, MD PhD, Wynne Weston-Davies, Miles A Nunn, DPhil, Yuzuru Kanakura, MD PhD, Ian J Mackie, Petra Muus, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1209.
https://doi.org/10.1182/blood.V126.23.1209.1209
Published: 2015